Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders ; volume:18 ; number:1 ; day:18 ; month:11 ; year:2021 ; pages:1-12 ; date:12.2021
Virology journal ; 18, Heft 1 (18.11.2021), 1-12, 12.2021
- Urheber
-
Ahmadi, Elham
Ravanshad, Mehrdad
Xie, Jun
Panigrahi, Rajesh
Jubbal, Sandeep S.
Guru, Santosh Kumar
Guangping, Gao
Ziyaeyan, Mazyar
Fingeroth, Joyce
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-021-01695-w
- URN
-
urn:nbn:de:101:1-2022012819560874276273
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ahmadi, Elham
- Ravanshad, Mehrdad
- Xie, Jun
- Panigrahi, Rajesh
- Jubbal, Sandeep S.
- Guru, Santosh Kumar
- Guangping, Gao
- Ziyaeyan, Mazyar
- Fingeroth, Joyce
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Adeno-Associated Virus (AAV) vectors in gene therapy
Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
AAV-Jahresbericht
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Adeno-Associated Virus (AAV) vectors in gene therapy
Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
AAV-Jahresbericht
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Adeno-Associated Virus (AAV) vectors in gene therapy
Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
AAV-Jahresbericht